Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-16

Clinical Trial Update: Study Assessing Double-masked Uveitis Treatment [Phase 3]

View source ↗

Summary

Phase 3 study of a double-masked treatment for posterior uveitis has completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Santen Inc.

Snippet

Sponsor: Santen Inc. | Conditions: Uveitis; Posterior, Disorder | Phase 3 | Status: COMPLETED | Results posted: 2019-07-16